Characterization of a mouse monoclonal IgG3 antibody to the tumor-associated globo H structure produced by immunization with a synthetic glycoconjugate

被引:30
|
作者
Kudryashov, V
Ragupathi, G
Kim, IJ
Breimer, ME
Danishefsky, SJ
Livingston, PO
Lloyd, KO
机构
[1] Mem Hosp, Program Immunol, New York, NY 10021 USA
[2] Mem Hosp, Mol Pharmacol & Therapeut Program, Sloan Kettering Inst, New York, NY 10021 USA
[3] Mem Hosp, Clin Immunol Serv, New York, NY 10021 USA
[4] Gothenburg Univ, Sahlgrenska Univ Hosp, Dept Surg, Gothenburg, Sweden
关键词
monoclonal antibody; globo H; synthetic oligosaccharides; tumor antigen; glycolipid;
D O I
10.1023/A:1006992911709
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Globo H (Fuc alpha 1-->2Gal beta 1-->3GalNAc beta 1-->3Gal alpha 1-->4Gal beta 1-->4Glc) is a carbohydrate structure that shows enhanced expression in many human carcinomas. From mice immunized with a globo H-KLH (keyhole limpet hemocyanin) synthetic conjugate an IgG3 monoclonal antibody (mAb VK-9) was derived that recognizes the globo H structure. Serological analysis showed that the minimal structure recognized by this mAb was the tetrasaccharide sequence Fuc alpha 1-->2Gal beta 1-->3Gal-NAc beta 1-->3Gal. An isomeric structure with an internal alpha GalNAc linkage was also recognized but less efficiently. mAb VK-9 did not react with many related structures, such as galactosylgloboside, globoside, H type 1, H type 2 blood group structures or fucosyl-gangliotetraosyl ceramide, but did react weakly with globo A ceramide. Not only did mAb VK-9 react with carbohydrate-protein conjugates but it could also recognize globo H-ceramide and human tumor cells expressing globo H. These results suggest that globo H-KLH could be explored as a vaccine in the treatment of carcinoma patients.
引用
收藏
页码:243 / 249
页数:7
相关论文
共 7 条
  • [1] Characterization of a mouse monoclonal IgG3 antibody to the tumor-associated globo H structure produced by immunization with a synthetic glycoconjugate
    Valery Kudryashov
    Govindaswami Ragupathi
    In Jong Kim
    Michael E Breimer
    Samuel J Danishefsky
    Philip O Livingston
    Kenneth O Lloyd
    Glycoconjugate Journal, 1998, 15 : 243 - 249
  • [2] PURIFICATION AND STABILIZATION OF A POORLY SOLUBLE MOUSE IGG3 MONOCLONAL-ANTIBODY
    JISKOOT, W
    HOVEN, AMV
    DEKONING, AAM
    LEERLING, MF
    REUBSAET, CHK
    CROMMELIN, DJA
    BEUVERY, EC
    JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 138 (02) : 181 - 189
  • [3] Molecular cloning of a tumor-associated antigen recognized by monoclonal antibody 3H11
    Chen, DH
    Shou, CC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 280 (01) : 99 - 103
  • [4] Phase I-II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor-associated carbohydrate antigen Globo H, in patients with advanced solid tumors
    Tsimberidou, Apostolia Maria
    Grothey, Axel
    Sigal, Darren
    Lenz, Heinz-Josef
    Hochster, Howard S.
    Chao, Yee
    Bai, Li-Yuan
    Yen, Chia-Jui L.
    Xu, Dong
    Saville, M. Wayne
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 94 (06) : 787 - 798
  • [5] Characterization of a novel mouse monoclonal antibody, clone 1E8.33, highly specific for human procollagen 11A1, a tumor-associated stromal component
    Garcia-Ocana, Marcos
    Vazquez, Fernando
    Garcia-Pravia, Carmen
    Fuentes-Martinez, Nelson
    Menendez-Rodriguez, Primitiva
    Fresno-Forcelledo, Florentino
    Barneo-Serra, Luis
    Del Amo-Iribarren, Jokin
    Simon-Buela, Laureano
    De los Toyos, Juan R.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (05) : 1447 - 1454
  • [6] MONOCLONAL-ANTIBODY LU-BCRU-G7 AGAINST A BREAST TUMOR-ASSOCIATED GLYCOPROTEIN RECOGNIZES THE DISACCHARIDE GAL-BETA-1-3GLCNAC
    RYE, PD
    BOVIN, NV
    VLASOVA, EV
    WALKER, RA
    GLYCOBIOLOGY, 1995, 5 (04) : 385 - 389
  • [7] A cell surface epitope associated with liver-preferential metastasis detected by the new monoclonal antibody 3H4 in the marine tumor model ER 15-P
    Wulf, GG
    Edel, G
    Deneke, B
    Gottschalk, U
    Hiddemann, W
    Wormann, B
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1996, 122 (08) : 476 - 482